Insider Trading History of Broshy Eran

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Broshy Eran since 2016. This trader's CIK number is 1256230. At the time of last reporting, Broshy Eran was the Officer of Theravance Biopharma, Inc.. (stock ticker symbol TBPH). Also see all insider trading activities at Theravance Biopharma, Inc..

Note that in the past BROSHY ERAN also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Certara, Inc. (CERT) by Broshy Eran

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 CERT 0 $0 0 $0 11,928 $0
2023 CERT 5,000 $79,057 0 $0 9,360 $0

Yearly summary of insider trading at Theravance Biopharma, Inc. (TBPH) by Broshy Eran

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 TBPH 0 $0 59,000 $1,062,000 0 $0

Yearly summary of insider trading at Magellan Health Inc (MGLN) by Broshy Eran

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 MGLN 0 $0 4,867 $389,360 0 $0
2016 MGLN 0 $0 2,433 $182,475 0 $0


Insider trading activities at 3 companies by Broshy Eran:

1. Certara, Inc. (CERT)

2. Theravance Biopharma, Inc. (TBPH)

3. Magellan Health Inc (MGLN)

Table 1. Insider trading of Certara, Inc. (CERT) by Broshy Eran

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-21 CERT Option Ex 11,928 .00 0
2023-08-22 CERT Buy 4,807 15.80 75,950
2023-08-21 CERT Buy 193 16.10 3,107
2023-05-23 CERT Option Ex 9,360 .00 0

Table 2. Insider trading of Theravance Biopharma, Inc. (TBPH) by Broshy Eran

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-11-11 TBPH Sale 59,000 18.00 1,062,000

Table 3. Insider trading of Magellan Health Inc (MGLN) by Broshy Eran

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-02-23 MGLN Sale 4,867 80.00 389,360
2016-12-08 MGLN Sale 2,433 75.00 182,475

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Broshy Eran (Officer of Theravance Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.